PortfoliosLab logo
EVH vs. COST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EVH and COST is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

EVH vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Evolent Health, Inc. (EVH) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%December2025FebruaryMarchAprilMay
-43.32%
765.64%
EVH
COST

Key characteristics

Sharpe Ratio

EVH:

-0.80

COST:

1.82

Sortino Ratio

EVH:

-1.01

COST:

2.39

Omega Ratio

EVH:

0.84

COST:

1.33

Calmar Ratio

EVH:

-0.78

COST:

2.32

Martin Ratio

EVH:

-1.26

COST:

6.89

Ulcer Index

EVH:

48.89%

COST:

5.83%

Daily Std Dev

EVH:

77.21%

COST:

22.14%

Max Drawdown

EVH:

-87.34%

COST:

-53.39%

Current Drawdown

EVH:

-73.10%

COST:

-6.24%

Fundamentals

Market Cap

EVH:

$1.16B

COST:

$443.26B

EPS

EVH:

-$0.81

COST:

$17.11

PEG Ratio

EVH:

-1.37

COST:

5.91

PS Ratio

EVH:

0.46

COST:

1.67

PB Ratio

EVH:

1.17

COST:

17.20

Total Revenue (TTM)

EVH:

$1.92B

COST:

$264.09B

Gross Profit (TTM)

EVH:

$233.08M

COST:

$35.11B

EBITDA (TTM)

EVH:

$65.68M

COST:

$11.25B

Returns By Period

In the year-to-date period, EVH achieves a -4.98% return, which is significantly lower than COST's 10.31% return.


EVH

YTD

-4.98%

1M

6.05%

6M

-54.43%

1Y

-60.55%

5Y*

10.36%

10Y*

N/A

COST

YTD

10.31%

1M

4.40%

6M

15.21%

1Y

36.24%

5Y*

29.28%

10Y*

23.64%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EVH vs. COST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EVH
The Risk-Adjusted Performance Rank of EVH is 1111
Overall Rank
The Sharpe Ratio Rank of EVH is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of EVH is 1212
Sortino Ratio Rank
The Omega Ratio Rank of EVH is 99
Omega Ratio Rank
The Calmar Ratio Rank of EVH is 66
Calmar Ratio Rank
The Martin Ratio Rank of EVH is 1616
Martin Ratio Rank

COST
The Risk-Adjusted Performance Rank of COST is 9191
Overall Rank
The Sharpe Ratio Rank of COST is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of COST is 9090
Sortino Ratio Rank
The Omega Ratio Rank of COST is 8989
Omega Ratio Rank
The Calmar Ratio Rank of COST is 9494
Calmar Ratio Rank
The Martin Ratio Rank of COST is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EVH vs. COST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Evolent Health, Inc. (EVH) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for EVH, currently valued at -0.80, compared to the broader market-2.00-1.000.001.002.003.00
EVH: -0.80
COST: 1.82
The chart of Sortino ratio for EVH, currently valued at -1.01, compared to the broader market-6.00-4.00-2.000.002.004.00
EVH: -1.01
COST: 2.39
The chart of Omega ratio for EVH, currently valued at 0.84, compared to the broader market0.501.001.502.00
EVH: 0.84
COST: 1.33
The chart of Calmar ratio for EVH, currently valued at -0.78, compared to the broader market0.001.002.003.004.005.00
EVH: -0.78
COST: 2.32
The chart of Martin ratio for EVH, currently valued at -1.26, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
EVH: -1.26
COST: 6.89

The current EVH Sharpe Ratio is -0.80, which is lower than the COST Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of EVH and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
-0.80
1.82
EVH
COST

Dividends

EVH vs. COST - Dividend Comparison

EVH has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.47%.


TTM20242023202220212020201920182017201620152014
EVH
Evolent Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COST
Costco Wholesale Corporation
0.47%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%0.97%

Drawdowns

EVH vs. COST - Drawdown Comparison

The maximum EVH drawdown since its inception was -87.34%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for EVH and COST. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-73.10%
-6.24%
EVH
COST

Volatility

EVH vs. COST - Volatility Comparison

Evolent Health, Inc. (EVH) has a higher volatility of 16.26% compared to Costco Wholesale Corporation (COST) at 10.18%. This indicates that EVH's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%December2025FebruaryMarchAprilMay
16.26%
10.18%
EVH
COST

Financials

EVH vs. COST - Financials Comparison

This section allows you to compare key financial metrics between Evolent Health, Inc. and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
646.54M
63.72B
(EVH) Total Revenue
(COST) Total Revenue
Values in USD except per share items

EVH vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between Evolent Health, Inc. and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%15.0%20.0%25.0%30.0%35.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
11.7%
15.1%
(EVH) Gross Margin
(COST) Gross Margin
EVH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Evolent Health, Inc. reported a gross profit of 75.71M and revenue of 646.54M. Therefore, the gross margin over that period was 11.7%.
COST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.
EVH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Evolent Health, Inc. reported an operating income of -18.60M and revenue of 646.54M, resulting in an operating margin of -2.9%.
COST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.
EVH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Evolent Health, Inc. reported a net income of -22.80M and revenue of 646.54M, resulting in a net margin of -3.5%.
COST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.